Impact of COVID-19 on the diagnosis and management of lung cancer and TB

Int J Tuberc Lung Dis. 2022 Apr 1;26(4):372-374. doi: 10.5588/ijtld.22.0045.

Authors

J W Kim¹, C Vella², W Parvez², R Verma¹, M Majid², G Woltmann¹, M Pareek³, J Bennett², S Agrawal², R Sudhir², L Ahyow⁴, M Tufail², P Haldar¹

Affiliations

¹ Department of Respiratory Sciences, University of Leicester, Leicester, Department of Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester.
² Department of Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester.
³ Department of Respiratory Sciences, University of Leicester, Leicester.
⁴ UK Health Security Agency, London, UK.

PMID: 35351244
DOI: 10.5588/ijtld.22.0045

No abstract available

MeSH terms

COVID-19*
Humans
Lung Neoplasms* / diagnosis
Lung Neoplasms* / therapy
Tuberculosis, Pulmonary* / diagnosis
Tuberculosis, Pulmonary* / drug therapy
Tuberculosis, Pulmonary* / epidemiology